Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04512261
Title TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Reva Basho
Indications

Her2-receptor positive breast cancer

Therapies

Pembrolizumab + Trastuzumab + Tucatinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.